HRMY — Harmony Biosciences Holdings, Inc. stock price, charts and financials

QT67Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
38.78
+3.18+8.93%
OverviewShort InterestFilings
HRMYQT67Harmony Biosciences Holdings, Inc.·NASDAQ
38.78+8.93%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 22, 20263Initial statement of beneficial ownership
Jul 16, 20268-KCurrent report
May 18, 20264Statement of changes in beneficial ownership
May 18, 20263Initial statement of beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20263Initial statement of beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 14, 20268-KCurrent report
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
Apr 14, 20268-KCurrent report
Apr 09, 20264Statement of changes in beneficial ownership
Apr 06, 20263Initial statement of beneficial ownership
Apr 06, 20264Statement of changes in beneficial ownership
Apr 06, 20264Statement of changes in beneficial ownership
Apr 03, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 306
Page
▼
/ 13